Several other research firms have also recently commented on DOCU. Citigroup lowered their target price on DocuSign from $114.00 to $90.00 and set a buy rating on the stock in a research report on Friday, June 10th. Wedbush cut DocuSign from a neutral rating to an underperform rating and lowered their target price for the company from $80.00 to $60.00 in a research report on Tuesday, May 3rd. Royal Bank of Canada decreased their price target on DocuSign from $85.00 to $80.00 in a research note on Friday, June 10th. Wells Fargo & Company decreased their price target on DocuSign from $80.00 to $63.00 and set an equal weight rating for the company in a research note on Friday, June 10th. Finally, JMP Securities decreased their price target on DocuSign from $180.00 to $151.00 and set a market outperform rating for the company in a research note on Friday, June 10th. Three equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and four have given a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of Hold and an average price target of $132.60.
Shares of DocuSign stock opened at $65.70 on Monday. DocuSign has a twelve month low of $55.96 and a twelve month high of $314.76. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.06. The stock has a market capitalization of $13.14 billion, a price-to-earnings ratio of -146.00 and a beta of 1.05. The business’s 50 day simple moving average is $78.21 and its 200-day simple moving average is $106.03.
In other news, COO Scott V. Olrich sold 3,948 shares of the firm’s stock in a transaction on Tuesday, April 5th. The stock was sold at an average price of $110.09, for a total value of $434,635.32. Following the completion of the sale, the chief operating officer now owns 230,663 shares of the company’s stock, valued at $25,393,689.67. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, COO Scott V. Olrich sold 12,500 shares of the firm’s stock in a transaction on Tuesday, March 29th. The stock was sold at an average price of $110.15, for a total value of $1,376,875.00. The disclosure for this sale can be found here. Company insiders own 2.55% of the company’s stock.
Several institutional investors have recently modified their holdings of DOCU. Vanguard Group Inc. raised its holdings in shares of DocuSign by 20.3% during the first quarter. Vanguard Group Inc. now owns 17,308,877 shares of the company’s stock worth $1,854,127,000 after acquiring an additional 2,917,683 shares in the last quarter. BlackRock Inc. raised its holdings in shares of DocuSign by 2.8% during the fourth quarter. BlackRock Inc. now owns 11,588,144 shares of the company’s stock worth $1,764,991,000 after acquiring an additional 313,959 shares in the last quarter. Capital World Investors raised its holdings in shares of DocuSign by 128.3% during the first quarter. Capital World Investors now owns 5,683,838 shares of the company’s stock worth $608,853,000 after acquiring an additional 3,193,727 shares in the last quarter. Polen Capital Management LLC raised its holdings in shares of DocuSign by 48.5% during the first quarter. Polen Capital Management LLC now owns 5,551,792 shares of the company’s stock worth $594,708,000 after acquiring an additional 1,813,284 shares in the last quarter. Finally, Fisher Asset Management LLC raised its holdings in shares of DocuSign by 51.9% during the first quarter. Fisher Asset Management LLC now owns 4,637,015 shares of the company’s stock worth $496,717,000 after acquiring an additional 1,584,989 shares in the last quarter. 75.62% of the stock is owned by institutional investors and hedge funds.
DocuSign Company Profile (Get Rating)
DocuSign, Inc provides electronic signature software in the United States and internationally. The company provides e-signature solution that enables businesses to digitally prepare, sign, act on, and manage agreements. It also offers CLM, which automates workflows across the entire agreement process; Insights that use artificial intelligence (AI) to search and analyze agreements by legal concepts and clauses; Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce; Negotiate for Salesforce that supports for approvals, document comparisons, and version control; Analyzer, which helps customers understand what they're signing before they sign it; and CLM+ that provide AI-driven contract lifecycle management.
- Get a free copy of the StockNews.com research report on DocuSign (DOCU)
- Zai Lab Stock Has Fallen to Value Levels
- Are These Cheap Copper Stocks Right For Your Portfolio?
- It’s A Comfortable Time To Buy Steelcase
- Worthington Posts Strong Results, But Earnings Fall On One-Off Adjustments
- A Tasty Entry Point Into Darden Restaurants International
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.